Cargando…

Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece

BACKGROUND: Assessing the overall burden of healthcare-associated infections (HAIs) is challenging, but imperative in evaluating the cost-effectiveness of infection control programs. This study aimed to estimate the point prevalence and annual incidence of HAIs in Greece and assess the excess length...

Descripción completa

Detalles Bibliográficos
Autores principales: Kritsotakis, Evangelos I, Kontopidou, Flora, Astrinaki, Eirini, Roumbelaki, Maria, Ioannidou, Eleni, Gikas, Achilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644569/
https://www.ncbi.nlm.nih.gov/pubmed/29066921
http://dx.doi.org/10.2147/IDR.S147459
_version_ 1783271750219333632
author Kritsotakis, Evangelos I
Kontopidou, Flora
Astrinaki, Eirini
Roumbelaki, Maria
Ioannidou, Eleni
Gikas, Achilles
author_facet Kritsotakis, Evangelos I
Kontopidou, Flora
Astrinaki, Eirini
Roumbelaki, Maria
Ioannidou, Eleni
Gikas, Achilles
author_sort Kritsotakis, Evangelos I
collection PubMed
description BACKGROUND: Assessing the overall burden of healthcare-associated infections (HAIs) is challenging, but imperative in evaluating the cost-effectiveness of infection control programs. This study aimed to estimate the point prevalence and annual incidence of HAIs in Greece and assess the excess length of stay (LOS) and mortality attributable to HAIs, overall and for main infection sites and tracer antimicrobial resistance (AMR) phenotypes and pathogens. PATIENTS AND METHODS: This prevalent cohort study used a nationally representative cross-section of 8,247 inpatients in 37 acute care hospitals to record active HAIs of all types at baseline and overall LOS and in-hospital mortality up to 90 days following hospital admission. HAI incidence was estimated using prevalence-to-incidence conversion methods. Excess mortality and LOS were assessed by Cox regression and multistate models correcting for confounding and time-dependent biases. RESULTS: HAIs were encountered with daily prevalence of 9.1% (95% confidence interval [CI] 7.8%–10.6%). The estimated annual HAI incidence was 5.2% (95% CI 4.4%–5.3%), corresponding to approximately 121,000 (95% CI 103,500–123,700) affected patients each year in the country. Ninety-day mortality risk was increased by 80% in patients with HAI compared to those without HAI (adjusted hazard ratio 1.8; 95% CI 1.3–2.6). Lower respiratory tract infections, bloodstream infections, and multiple concurrent HAIs doubled the risk of death, whereas surgical site and urinary tract infections were not associated with increased mortality. AMR had significant impact on the daily risk of 90-day mortality, which was increased by 90%–110% in patients infected by carbapenem-resistant gram-negative pathogens. HAIs increased LOS for an average of 4.3 (95% CI 2.4–6.2) additional days. Mean excess LOS exceeded 20 days in infections caused by major carbapenem-resistant gram-negative pathogens. CONCLUSION: HAIs, alongside with increasing AMR, pose significant burden to the hospital system. Burden estimates obtained in this study will be valuable in future evaluations of infection prevention programs.
format Online
Article
Text
id pubmed-5644569
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-56445692017-10-24 Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece Kritsotakis, Evangelos I Kontopidou, Flora Astrinaki, Eirini Roumbelaki, Maria Ioannidou, Eleni Gikas, Achilles Infect Drug Resist Original Research BACKGROUND: Assessing the overall burden of healthcare-associated infections (HAIs) is challenging, but imperative in evaluating the cost-effectiveness of infection control programs. This study aimed to estimate the point prevalence and annual incidence of HAIs in Greece and assess the excess length of stay (LOS) and mortality attributable to HAIs, overall and for main infection sites and tracer antimicrobial resistance (AMR) phenotypes and pathogens. PATIENTS AND METHODS: This prevalent cohort study used a nationally representative cross-section of 8,247 inpatients in 37 acute care hospitals to record active HAIs of all types at baseline and overall LOS and in-hospital mortality up to 90 days following hospital admission. HAI incidence was estimated using prevalence-to-incidence conversion methods. Excess mortality and LOS were assessed by Cox regression and multistate models correcting for confounding and time-dependent biases. RESULTS: HAIs were encountered with daily prevalence of 9.1% (95% confidence interval [CI] 7.8%–10.6%). The estimated annual HAI incidence was 5.2% (95% CI 4.4%–5.3%), corresponding to approximately 121,000 (95% CI 103,500–123,700) affected patients each year in the country. Ninety-day mortality risk was increased by 80% in patients with HAI compared to those without HAI (adjusted hazard ratio 1.8; 95% CI 1.3–2.6). Lower respiratory tract infections, bloodstream infections, and multiple concurrent HAIs doubled the risk of death, whereas surgical site and urinary tract infections were not associated with increased mortality. AMR had significant impact on the daily risk of 90-day mortality, which was increased by 90%–110% in patients infected by carbapenem-resistant gram-negative pathogens. HAIs increased LOS for an average of 4.3 (95% CI 2.4–6.2) additional days. Mean excess LOS exceeded 20 days in infections caused by major carbapenem-resistant gram-negative pathogens. CONCLUSION: HAIs, alongside with increasing AMR, pose significant burden to the hospital system. Burden estimates obtained in this study will be valuable in future evaluations of infection prevention programs. Dove Medical Press 2017-10-10 /pmc/articles/PMC5644569/ /pubmed/29066921 http://dx.doi.org/10.2147/IDR.S147459 Text en © 2017 Kritsotakis et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Kritsotakis, Evangelos I
Kontopidou, Flora
Astrinaki, Eirini
Roumbelaki, Maria
Ioannidou, Eleni
Gikas, Achilles
Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece
title Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece
title_full Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece
title_fullStr Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece
title_full_unstemmed Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece
title_short Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece
title_sort prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in greece
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644569/
https://www.ncbi.nlm.nih.gov/pubmed/29066921
http://dx.doi.org/10.2147/IDR.S147459
work_keys_str_mv AT kritsotakisevangelosi prevalenceincidenceburdenandclinicalimpactofhealthcareassociatedinfectionsandantimicrobialresistanceanationalprevalentcohortstudyinacutecarehospitalsingreece
AT kontopidouflora prevalenceincidenceburdenandclinicalimpactofhealthcareassociatedinfectionsandantimicrobialresistanceanationalprevalentcohortstudyinacutecarehospitalsingreece
AT astrinakieirini prevalenceincidenceburdenandclinicalimpactofhealthcareassociatedinfectionsandantimicrobialresistanceanationalprevalentcohortstudyinacutecarehospitalsingreece
AT roumbelakimaria prevalenceincidenceburdenandclinicalimpactofhealthcareassociatedinfectionsandantimicrobialresistanceanationalprevalentcohortstudyinacutecarehospitalsingreece
AT ioannidoueleni prevalenceincidenceburdenandclinicalimpactofhealthcareassociatedinfectionsandantimicrobialresistanceanationalprevalentcohortstudyinacutecarehospitalsingreece
AT gikasachilles prevalenceincidenceburdenandclinicalimpactofhealthcareassociatedinfectionsandantimicrobialresistanceanationalprevalentcohortstudyinacutecarehospitalsingreece